Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...

Electrical Current

Electrical Current

Electrical current is defined as the rate at which charge flows. When there is a large current present, such as that used to run a refrigerator, a large amount of charge moves through the wire in a small amount of time. If the current is small, such as that used to operate a handheld calculator, a small amount of charge moves through the circuit over a long period of time. The SI unit for current is the ampere (A), named for the French physicist André-Marie Ampère (1775–1836).

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transcranial ultrasound stimulation of motor networks in Parkinson's disease informed by local field potential dynamics.

Science translational medicine·2026

Same author

Depressive symptoms, but not OSA severity, are associated with general fatigue in myasthenia gravis.

Sleep medicine·2026

Same author

Association between statin use and survival in patients with ALS: A propensity score-matched analysis.

Journal of the neurological sciences·2026

Same author

The Muscle Cramp Impact Index: A Patient-Centered Scale for the Assessment of Muscle Cramps.

Neurology·2026

Same author

Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis.

Nature genetics·2026

Same author

Neuropsychiatric Symptom Clusters and Their Association With Brain Structure in Alzheimer Disease.

The Journal of clinical psychiatry·2026

Same journal

IgG Subclass (IgG1-4) and IgA Autoantibody Profiles Against Muscle-Specific Kinase in a Greek Cohort.

Muscle & nerve·2026

Same journal

Mindfulness for Myasthenia Gravis.

Muscle & nerve·2026

Same journal

Cure in Myasthenia Gravis: An Unmet Need.

Muscle & nerve·2026

Same journal

Treatment Preferences of Patients With Myasthenia Gravis: A Qualitative Study.

Muscle & nerve·2026

Same journal

At-Home Versus in-Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial.

Muscle & nerve·2026

Same journal

The Use of the Four Square Step Test and the 10-m Walk/Run Test to Determine Fall Risk in Children With Duchenne Muscular Dystrophy.

Muscle & nerve·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 8, 2026

Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation

Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation

Published on: June 17, 2013

Current and Ongoing Clinical Studies.

Agessandro Abrahao¹, Lorne Zinman¹, Stephen Apple²

¹Division of Neurology, Department of Medicine and Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

|February 7, 2026

Summary

This summary is machine-generated.

Ongoing studies evaluate edaravone (intravenous and oral suspension) for amyotrophic lateral sclerosis (ALS) treatment. Research aims to clarify efficacy, safety, and biological impact, supporting edaravone as a key ALS therapy option.

Keywords:

ALS amyotrophic lateral sclerosis clinical clinical trials edaravone

More Related Videos

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

Related Experiment Videos

Last Updated: Feb 8, 2026

Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation

Simultaneous EEG Monitoring During Transcranial Direct Current Stimulation

Published on: June 17, 2013

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Transcranial Direct Current Stimulation tDCS for Memory Enhancement

Published on: September 18, 2021

Area of Science:

Neurology
Pharmacology
Clinical Research

Background:

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited treatment options.
Edaravone, available as intravenous (IV) and oral suspension, is an emerging therapeutic agent for ALS.
Understanding the full clinical utility of edaravone requires ongoing evaluation in diverse study settings.

Purpose of the Study:

To provide a comprehensive overview of current and planned studies on edaravone for ALS treatment.
To assess the efficacy, safety, and biological mechanisms of edaravone in various clinical contexts.
To inform optimal treatment strategies and future therapeutic approaches for ALS.

Main Methods:

Review of ongoing and completed clinical trials and observational studies.
Analysis of data from postmarketing surveillance and natural history registries.
Inclusion of biomarker data to explore edaravone's pathophysiologic impact.

Main Results:

Multiple studies are evaluating both IV edaravone and oral edaravone suspension.
Ongoing research includes long-term surveillance, natural history tracking, and biomarker analysis.
Clinical trials have supported the safety, tolerability, and efficacy of edaravone formulations.

Conclusions:

Current and ongoing studies collectively support edaravone as a valuable therapeutic option for ALS.
Continued data collection from clinical trials and practice is crucial for refining edaravone treatment.
These efforts will guide optimal strategies and combination therapies in the evolving ALS landscape.